• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉米夫定治疗 HIV。

Lamivudine for the treatment of HIV.

机构信息

Division of Infectious Diseases, Georgetown University, Washington, DC 20007, USA.

出版信息

Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):105-14. doi: 10.1517/17425250903490418.

DOI:10.1517/17425250903490418
PMID:20001611
Abstract

Lamivudine is a nucleoside reverse transcriptase inhibitor that is widely used for the treatment of HIV-1 infection in combination with other antiretrovirals. It is a highly effective agent that can be dosed once or twice daily due to its long intracellular half-life. It also has one of the best tolerability and long-term safety profiles among all antiretroviral agents and continues to be preferred as part of initial or subsequent combination therapy in HIV-infected patients.

摘要

拉米夫定是一种核苷类逆转录酶抑制剂,广泛用于与其他抗逆转录病毒药物联合治疗 HIV-1 感染。由于其较长的细胞内半衰期,它是一种非常有效的药物,可以每日一次或两次给药。它也是所有抗逆转录病毒药物中耐受性和长期安全性最好的药物之一,并且仍然是 HIV 感染患者初始或后续联合治疗的首选药物之一。

相似文献

1
Lamivudine for the treatment of HIV.拉米夫定治疗 HIV。
Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):105-14. doi: 10.1517/17425250903490418.
2
[New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success].[新型每日一次固定剂量组合作为核苷主干。长期治疗成功的基础]
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:66-8.
3
Emtricitabine: new preparation. An antiretroviral very similar to lamivudine.恩曲他滨:新制剂。一种与拉米夫定非常相似的抗逆转录病毒药物。
Prescrire Int. 2005 Apr;14(76):54-6.
4
[Improved long-term success. New nucleoside for once daily combinations].[提高长期成功率。用于每日一次联合用药的新型核苷]
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:31-3.
5
Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.安普那韦联合拉米夫定和齐多夫定与拉米夫定和齐多夫定单药治疗初治的HIV-1感染成人的疗效比较。安普那韦PROAB3001国际研究团队。
Antivir Ther. 2000 Sep;5(3):215-25.
6
Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.围产期暴露于核苷类逆转录酶抑制剂的健康风险特刊。
Environ Mol Mutagen. 2007 Apr-May;48(3-4):159-65. doi: 10.1002/em.20296.
7
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.阿凡提2. 一项随机、双盲试验,旨在评估齐多夫定加拉米夫定与齐多夫定加拉米夫定加茚地那韦在未接受过抗逆转录病毒治疗的HIV感染患者中的疗效和安全性。
AIDS. 2000 Mar 10;14(4):367-74.
8
Abacavir and lamivudine combination.阿巴卡韦和拉米夫定联合。
Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1599-606. doi: 10.1517/17425250903439720.
9
A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.在感染HIV的儿童中,于当前核苷类逆转录酶抑制剂治疗基础上加用拉米夫定或匹配安慰剂的随机双盲试验:PENTA-4试验。欧洲儿科艾滋病治疗网络
AIDS. 1998 Oct 1;12(14):F151-60.
10
Reverse transcriptase fidelity and HIV-1 variation.逆转录酶保真度与HIV-1变异
Science. 1997 Jan 10;275(5297):229-30; author reply 230-1.

引用本文的文献

1
Simultaneous Quantification of Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Human Plasma by UPLC-MS/MS: Method Development and Validation.超高效液相色谱-串联质谱法同时测定人血浆中多拉韦林、拉米夫定和替诺福韦酯富马酸盐:方法开发与验证
Turk J Pharm Sci. 2025 Aug 1;22(3):191-206. doi: 10.4274/tjps.galenos.2025.70718.
2
Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action.鉴定一种具有非核苷作用模式的新型HIV-1逆转录酶活性小分子抑制剂。
Virol J. 2025 Mar 7;22(1):65. doi: 10.1186/s12985-025-02680-3.
3
Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation.
初治和经治 HIV-1 感染者携带 M184V 突变的治疗管理挑战。
Viruses. 2024 Aug 30;16(9):1392. doi: 10.3390/v16091392.
4
Application of signal processing techniques for the spectroscopic analysis of dolutegravir and lamivudine: a comparative assessment and greenness appraisal.信号处理技术在多替拉韦和拉米夫定光谱分析中的应用:比较评估与绿色度评价
BMC Chem. 2024 Jul 8;18(1):129. doi: 10.1186/s13065-024-01226-y.
5
Prescribing for patients taking antiretroviral therapy.为接受抗逆转录病毒治疗的患者开处方。
Aust Prescr. 2022 Jun;45(3):80-87. doi: 10.18773/austprescr.2022.026. Epub 2022 Jun 1.
6
Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals.抗逆转录病毒治疗诱导 HIV+ 患者基因表达和脂质代谢紊乱:抗氧化植物化学物质的有益作用。
Int J Mol Sci. 2022 May 17;23(10):5592. doi: 10.3390/ijms23105592.
7
HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.在真实世界临床实践中使用多替拉韦加拉米夫定两药方案进行HIV治疗:一项系统文献综述
Infect Dis Ther. 2021 Dec;10(4):2051-2070. doi: 10.1007/s40121-021-00522-7. Epub 2021 Aug 24.
8
Bioequivalence and Food Effect Assessment of 2 Fixed-Dose Combination Formulations of Dolutegravir and Lamivudine.度鲁特韦/拉米夫定 2 种固定剂量复方制剂的生物等效性和食物影响评估。
Clin Pharmacol Drug Dev. 2020 Feb;9(2):189-202. doi: 10.1002/cpdd.740. Epub 2019 Nov 14.
9
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.拉米夫定 25 年:目前和未来用于治疗 HIV-1 感染。
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):125-135. doi: 10.1097/QAI.0000000000001660.
10
Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children.拉米夫定在HIV感染儿童中的协变量效应及群体药代动力学
Br J Clin Pharmacol. 2014 May;77(5):861-72. doi: 10.1111/bcp.12247.